Parnax Lab Ltd vs Apollo Hospitals Enterprise Ltd

A side-by-side comparison of Parnax Lab Ltd (506128) and Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Ltd leads 506128 vs APOLLOHOSP on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

13.80
P/E ratio
66.33
1.71
P/B ratio
12.55
0.00%
Dividend yield
0.22%
₹10.03
EPS
₹135.04

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

14.40%
Return on equity
22.10%
14.00%
Return on capital
18.00%
14.00%
EBITDA margin
15.00%
6.38%
Net margin
7.94%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.95%
Revenue CAGR (3Y)
14.94%
10.91%
Profit CAGR (3Y)
33.39%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹159 Cr
Market cap
₹1.29L Cr
₹188 Cr
Revenue
₹25,228 Cr
₹12 Cr
Net profit
₹2,003 Cr
0.87
Debt / equity
0.32
Parnax Lab Ltd
  • + ["Company is expected to give good quarter"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company might be capitalizing the interest cost"]
Apollo Hospitals Enterprise Ltd
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.6 times its book value", "Company might be capitalizing the interest cost"]
Parnax Lab Ltd full analysis Apollo Hospitals Enterprise Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.